We have recently identified 2 patients with a rare autosomal recessive form of hyper IgM disease, known as HIGM3, caused by mutations in the CD40 gene. These patients had opportunistic infections observed on X-linked hyper IgM syndrome (HIGM), suggesting that the CD40-CD40 ligand interaction is important for promoting T-cell-mediated immunity. To evaluate whether innate immunity signals may substitute CD154 for inducing the maturation of dendritic cells (DCs), we analyzed monocyte-derived DCs in these patients. Monocyte-derived DCs of HIGM3 subjects on ex vivo stimulation with tumor necrosis factor-alpha (TNP-alpha) or lipopolysaccharide (LIPS) combined with interferon-gamma (IFN-gamma) normally express all the markers of mature DCs, such as CD83 and DC-LAMP. However, cell surface levels of HLA-DR in mature DCs are reduced, as is costimulatory activity of these cells for allogeneic naive T cells. In addition, CD40-deficient DCs secrete lower amounts of interieukin-12 (IL-12) but larger quantities of IL-10 than control subjects. Finally, analysis of circulating plasmacytoid DCs demonstrates a normal percentage of this subset in CD40-deficient cells, but IFN-alpha secretion in response to herpes simplex virus 1 (HSV-1) infection is severely reduced in patients. These observations suggest that the severe impairment of DC maturation may contribute to the defect of T-cell-mediated immunity observed in HIGM3 patients. (C) 2003 by The American Society of Hematology.

Functional defects of dendritic cells in patients with CD40 deficiency / S., Fontana; D., Moratto; S., Mangal; M., De Francesco; W., Vermi; S., Ferrari; F., Facchetti; N., Kutukculer; C., Fiorini; Duse, Marzia; P. K., Das; L. D., Notarangelo; A., Plebani; R., Badolato. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 102:12(2003), pp. 4099-4106. (Intervento presentato al convegno Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-CytokineResearch/European-Cytokine-Society/Society-for-Leukocyte-Biology tenutosi a TURIN, ITALY nel OCT 06-10, 2002) [10.1182/blood-2003-04-1244].

Functional defects of dendritic cells in patients with CD40 deficiency

DUSE, MARZIA;
2003

Abstract

We have recently identified 2 patients with a rare autosomal recessive form of hyper IgM disease, known as HIGM3, caused by mutations in the CD40 gene. These patients had opportunistic infections observed on X-linked hyper IgM syndrome (HIGM), suggesting that the CD40-CD40 ligand interaction is important for promoting T-cell-mediated immunity. To evaluate whether innate immunity signals may substitute CD154 for inducing the maturation of dendritic cells (DCs), we analyzed monocyte-derived DCs in these patients. Monocyte-derived DCs of HIGM3 subjects on ex vivo stimulation with tumor necrosis factor-alpha (TNP-alpha) or lipopolysaccharide (LIPS) combined with interferon-gamma (IFN-gamma) normally express all the markers of mature DCs, such as CD83 and DC-LAMP. However, cell surface levels of HLA-DR in mature DCs are reduced, as is costimulatory activity of these cells for allogeneic naive T cells. In addition, CD40-deficient DCs secrete lower amounts of interieukin-12 (IL-12) but larger quantities of IL-10 than control subjects. Finally, analysis of circulating plasmacytoid DCs demonstrates a normal percentage of this subset in CD40-deficient cells, but IFN-alpha secretion in response to herpes simplex virus 1 (HSV-1) infection is severely reduced in patients. These observations suggest that the severe impairment of DC maturation may contribute to the defect of T-cell-mediated immunity observed in HIGM3 patients. (C) 2003 by The American Society of Hematology.
2003
01 Pubblicazione su rivista::01a Articolo in rivista
Functional defects of dendritic cells in patients with CD40 deficiency / S., Fontana; D., Moratto; S., Mangal; M., De Francesco; W., Vermi; S., Ferrari; F., Facchetti; N., Kutukculer; C., Fiorini; Duse, Marzia; P. K., Das; L. D., Notarangelo; A., Plebani; R., Badolato. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 102:12(2003), pp. 4099-4106. (Intervento presentato al convegno Joint Meeting of the International-Cytokine-Society/International-Society-for-Interferon-and-CytokineResearch/European-Cytokine-Society/Society-for-Leukocyte-Biology tenutosi a TURIN, ITALY nel OCT 06-10, 2002) [10.1182/blood-2003-04-1244].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/93635
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 39
social impact